Venlafaxine



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 41.8%
Depression 30.6%
Major Depression 4.7%
Anxiety 4.2%
Bipolar Disorder 2.8%
Drug Use For Unknown Indication 2.3%
Schizophrenia 1.9%
Pain 1.7%
Insomnia 1.4%
Overdose 1.2%
Convulsion 0.9%
Generalised Anxiety Disorder 0.8%
Hypertension 0.8%
Anxiety Disorder 0.8%
Cataplexy 0.8%
Headache 0.7%
Multiple Drug Overdose 0.7%
Prophylaxis Of Neural Tube Defect 0.7%
Obsessive-compulsive Disorder 0.7%
Drug Dependence 0.6%
Product Substitution Issue 13.3%
Toxicity To Various Agents 11.1%
Poisoning 7.3%
Tremor 6.4%
Withdrawal Syndrome 6.2%
Vomiting 5.9%
Serotonin Syndrome 5.7%
Stress Cardiomyopathy 5.2%
Suicidal Ideation 5.2%
Drug Ineffective 4.3%
Depression 3.8%
Respiratory Arrest 3.8%
Drug Interaction 3.6%
Suicide Attempt 3.3%
Syncope 2.8%
Dizziness 2.6%
Overdose 2.6%
Urinary Tract Infection 2.4%
Vision Blurred 2.4%
Agitation 2.1%
Secondary
Product Used For Unknown Indication 46.4%
Depression 12.6%
Drug Use For Unknown Indication 9.9%
Suicide Attempt 4.6%
Drug Abuse 3.4%
Bipolar Disorder 3.4%
Major Depression 2.9%
Anxiety 2.5%
Multiple Drug Overdose 2.3%
Hypertension 1.5%
Psychotic Disorder Due To A General Medical Condition 1.4%
Pain 1.4%
Psychotic Disorder 1.2%
Intentional Overdose 1.2%
Drug Dependence 1.0%
Schizophrenia 1.0%
Headache 0.9%
Mental Disorder 0.8%
Completed Suicide 0.8%
Ill-defined Disorder 0.8%
Completed Suicide 23.2%
Toxicity To Various Agents 13.5%
Serotonin Syndrome 9.0%
Respiratory Arrest 5.5%
Drug Toxicity 4.8%
Vomiting 4.6%
Death 4.4%
Poisoning 4.1%
Cardio-respiratory Arrest 3.6%
Overdose 3.4%
Suicide Attempt 3.4%
Drug Abuse 2.8%
Intentional Drug Misuse 2.5%
Weight Increased 2.5%
Sopor 2.4%
Weight Decreased 2.4%
Syncope 2.2%
Hyponatraemia 2.1%
Cardiac Arrest 1.9%
Tachycardia 1.9%
Concomitant
Product Used For Unknown Indication 33.8%
Depression 16.2%
Drug Use For Unknown Indication 7.6%
Hypertension 5.5%
Anxiety 4.8%
Pain 4.4%
Schizophrenia 4.3%
Prophylaxis 3.9%
Rheumatoid Arthritis 2.6%
Multiple Sclerosis 2.5%
Bipolar Disorder 1.9%
Blood Cholesterol Increased 1.5%
Crohn's Disease 1.5%
Gastrooesophageal Reflux Disease 1.4%
Diabetes Mellitus 1.4%
Insomnia 1.4%
B-cell Lymphoma 1.4%
Osteoporosis 1.3%
Sleep Disorder 1.3%
Major Depression 1.3%
Vomiting 9.8%
Weight Decreased 8.7%
Weight Increased 6.9%
White Blood Cell Count Decreased 6.6%
Somnolence 6.0%
Pain 5.3%
Toxicity To Various Agents 4.8%
Tremor 4.7%
Urinary Tract Infection 4.7%
Pneumonia 4.6%
Drug Ineffective 4.3%
Nausea 4.3%
White Blood Cell Count Increased 4.3%
Death 4.1%
Suicide Attempt 4.1%
Pulmonary Embolism 4.0%
Tachycardia 3.8%
Vision Blurred 3.2%
Fatigue 2.9%
Malaise 2.9%
Interacting
Product Used For Unknown Indication 29.7%
Mental Disorder 14.2%
Major Depression 12.1%
Depression 9.0%
Hypertension 4.4%
Anxiety 3.0%
Hypothyroidism 3.0%
Back Pain 2.5%
Essential Hypertension 2.5%
Pain 2.5%
Schizophrenia 2.5%
Somatoform Disorder 2.4%
Insomnia 1.9%
Bipolar Disorder 1.6%
Convulsion 1.6%
Agitation 1.5%
Smoking Cessation Therapy 1.5%
Blood Cholesterol Increased 1.3%
Drug Use For Unknown Indication 1.3%
Type 2 Diabetes Mellitus 1.3%
Drug Interaction 23.4%
Serotonin Syndrome 22.7%
Drug Ineffective 7.0%
Antidepressant Drug Level Above Therapeutic 5.5%
Homicide 3.9%
Suicidal Ideation 3.9%
Syncope 3.9%
Drug Toxicity 3.1%
Hyponatraemia 3.1%
Somnolence 3.1%
Withdrawal Syndrome 3.1%
Agitation 2.3%
Akathisia 2.3%
Overdose 2.3%
Tremor 2.3%
Abnormal Weight Gain 1.6%
Antipsychotic Drug Level Above Therapeutic 1.6%
Drug Level Increased 1.6%
Electrocardiogram St-t Segment Elevation 1.6%
Gastrointestinal Disorder 1.6%